Suresh K. Durgam M.D.
Net Worth
Last updated:
What is Suresh K. Durgam M.D. net worth?
The estimated net worth of Dr. Suresh K. Durgam M.D. is at least $15,584,499 as of 11 Mar 2024. He owns shares worth $2,611,422 as insider, has earned $10,051,637 from insider trading and has received compensation worth at least $2,921,440 in Intra-Cellular Therapies, Inc..
What is the salary of Suresh K. Durgam M.D.?
Dr. Suresh K. Durgam M.D. salary is $730,360 per year as Senior Vice President & Chief Medical Officer in Intra-Cellular Therapies, Inc..
How old is Suresh K. Durgam M.D.?
Dr. Suresh K. Durgam M.D. is 56 years old, born in 1969.
What stocks does Suresh K. Durgam M.D. currently own?
As insider, Dr. Suresh K. Durgam M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) | Senior Vice President & Chief Medical Officer | 19,803 | $131.87 | $2,611,422 |
What does Intra-Cellular Therapies, Inc. do?
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.
Suresh K. Durgam M.D. insider trading
Intra-Cellular Therapies, Inc.
Dr. Suresh K. Durgam M.D. has made 37 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 872 units of ITCI stock worth $57,456 on 11 Mar 2024.
The largest trade he's ever made was exercising 62,282 units of ITCI stock on 2 Jan 2024. As of 11 Mar 2024 he still owns at least 19,803 units of ITCI stock.
Intra-Cellular Therapies key executives
Intra-Cellular Therapies, Inc. executives and other stock owners filed with the SEC:
- Dr. Sharon Mates (72) Co-Founder, Chairman, Chief Executive Officer & Pres
- Dr. Suresh K. Durgam M.D. (56) Senior Vice President & Chief Medical Officer
- Mr. Lawrence J. Hineline CPA, CPA (69) Senior Vice President of Fin., Chief Financial Officer, Treasurer & Assistant Sec.
- Mr. Mark Neumann (62) EVice President & Chief Commercial Officer
- Mr. Michael I. Halstead J.D. (52) Executive Vice President, Gen. Counsel & Sec.